March 24, 2020 / 12:18 PM / 9 days ago

BRIEF-DiaCarta Has Filed For EUA With The FDA And Has Received CE Mark For Its Highly Sensitive Quantivirus SARS-CoV-2 Test

March 24 (Reuters) -

* DIACARTA INC. HAS FILED FOR EUA WITH THE FDA AND HAS RECEIVED CE MARK FOR ITS HIGHLY SENSITIVE QUANTIVIRUS™ SARS-COV-2 TEST

* DIACARTA INC. HAS FILED FOR EUA WITH FDA AND HAS RECEIVED CE MARK FOR ITS HIGHLY SENSITIVE QUANTIVIRUS SARS-COV-2 TEST Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below